MD782Z - Metodă de vaccinare contra gripei - Google Patents
Metodă de vaccinare contra gripei Download PDFInfo
- Publication number
- MD782Z MD782Z MDS20140008A MDS20140008A MD782Z MD 782 Z MD782 Z MD 782Z MD S20140008 A MDS20140008 A MD S20140008A MD S20140008 A MDS20140008 A MD S20140008A MD 782 Z MD782 Z MD 782Z
- Authority
- MD
- Moldova
- Prior art keywords
- influenza
- people
- capsule
- vaccination
- vaccine
- Prior art date
Links
- 206010022000 influenza Diseases 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 10
- 238000002255 vaccination Methods 0.000 title claims description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 10
- 239000002775 capsule Substances 0.000 claims abstract description 9
- 229920002261 Corn starch Polymers 0.000 claims abstract description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 5
- 239000008120 corn starch Substances 0.000 claims abstract description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 5
- 235000012054 meals Nutrition 0.000 claims abstract description 4
- 229960003971 influenza vaccine Drugs 0.000 claims description 11
- 241000700605 Viruses Species 0.000 abstract description 5
- 229960005486 vaccine Drugs 0.000 abstract description 4
- 238000011321 prophylaxis Methods 0.000 abstract description 3
- 208000035473 Communicable disease Diseases 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 230000001681 protective effect Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 5
- 230000004957 immunoregulator effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000712461 unidentified influenza virus Species 0.000 description 4
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000002649 immunization Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 description 2
- 102000005348 Neuraminidase Human genes 0.000 description 2
- 108010006232 Neuraminidase Proteins 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000027645 antigenic variation Effects 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 210000000852 deltoid muscle Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 241000371980 Influenza B virus (B/Shanghai/361/2002) Species 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003312 immunocapture Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037801 influenza A (H1N1) Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003771 laboratory diagnosis Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 201000010740 swine influenza Diseases 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20140008A MD782Z (mo) | 2013-07-16 | 2013-07-16 | Metodă de vaccinare contra gripei |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20140008A MD782Z (mo) | 2013-07-16 | 2013-07-16 | Metodă de vaccinare contra gripei |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD782Y MD782Y (ro) | 2014-06-30 |
| MD782Z true MD782Z (mo) | 2015-01-31 |
Family
ID=51022558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20140008A MD782Z (mo) | 2013-07-16 | 2013-07-16 | Metodă de vaccinare contra gripei |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD782Z (mo) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3120G2 (ro) * | 2005-09-15 | 2007-03-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Metodă de profilaxie a gripei |
| MD4177C1 (ro) * | 2011-01-14 | 2013-02-28 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Metodă de vaccinare contra hepatitei virale B a persoanelor imunocompromise |
-
2013
- 2013-07-16 MD MDS20140008A patent/MD782Z/mo not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3120G2 (ro) * | 2005-09-15 | 2007-03-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Metodă de profilaxie a gripei |
| MD4177C1 (ro) * | 2011-01-14 | 2013-02-28 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Metodă de vaccinare contra hepatitei virale B a persoanelor imunocompromise |
Non-Patent Citations (1)
| Title |
|---|
| Alexandrescu V., Matei D., Sbâcea C. Ghid de diagnostic, tratament şi prevenire a gripei. Bucureşti, 2009, Editura Almatea, p. 59 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD782Y (ro) | 2014-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6247639B2 (ja) | 経鼻インフルエンザワクチン組成物 | |
| Pillet et al. | A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults | |
| Yoo et al. | Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice | |
| CN102215864A (zh) | 用于抗流感的疫苗组合物 | |
| Rudenko et al. | Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study | |
| Gorse et al. | Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18–64 years of age | |
| Li et al. | Intranasal co-administration of 1, 8-cineole with influenza vaccine provide cross-protection against influenza virus infection | |
| ES2606541T3 (es) | Proteína CC10 humana recombinante para el tratamiento de la gripe | |
| TWI721949B (zh) | 流行性感冒疫苗經鼻接種系統 | |
| CN101450209B (zh) | 透皮免疫流感多价疫苗的制备及其方法 | |
| TWI801328B (zh) | 包括咪喹莫特的局部調配物之用途 | |
| CN114761040A (zh) | 用于增强对疫苗接种的免疫反应和改善疫苗生产的组合物和方法 | |
| Stiver | The threat and prospects for control of an influenza pandemic | |
| Schwab et al. | Avianized rabies virus vaccination in man | |
| CN107469075A (zh) | 一种高剂量四价流感疫苗组合物 | |
| TW201628645A (zh) | 皮內投與之流感疫苗組成物 | |
| Scheerlinck et al. | Local immune responses following nasal delivery of an adjuvanted influenza vaccine | |
| MD782Z (mo) | Metodă de vaccinare contra gripei | |
| TW202122413A (zh) | 可於鼻腔誘導病毒特異性抗體之季節性流感疫苗 | |
| Evseenko et al. | Saponins extracted from Polemonium caeruleum have adjuvant activity in guinea pig intranasal immunization with trivalent influenza antigens | |
| JP5846624B2 (ja) | Ｈ５ｎ１型インフルエンザワクチン及び感染防御キット | |
| JP2010529166A5 (mo) | ||
| JP2010529166A (ja) | 皮内インフルエンザワクチン | |
| Golahdooz et al. | Comparison of immune responses following intradermal and intramuscular rabies vaccination methods | |
| RU2502512C2 (ru) | Способ лечения гриппа птиц |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |